Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Kodiak Sciences Inc. has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct art units and examiners, indicating overlap in the technical or personnel assignments for the portfolio.
LOCKARD, JON MCCLELLAND serves as the busiest examiner, responsible for 2 pending office actions. This concentration means that most of the current prosecution activity is being handled by this examiner, while the remaining pending action is managed by a different individual.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (67%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LOCKARD, JON MCCLELLAND | 2 | 74.6% | +27.2% |
| PARK, HAEJIN S | 1 | 55.0% | +38.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16795450 | DUAL PDGF/VEGF ANTAGONISTS | LOCKARD, JON MCCLELLAND | 72d overdue |
| 18490182 | MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES | PARK, HAEJIN S | — |
| 18555122 | METHODS OF TREATING AN EYE DISORDER | LOCKARD, JON MCCLELLAND | — |
| Art Unit | Apps |
|---|---|
| 1647 | 2 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18490182 | MULTIFUNCTIONAL ZWITTERIONIC POLYMER CONJUGATES | PARK, HAEJIN S | 1614 | §112 | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18555122 | METHODS OF TREATING AN EYE DISORDER | LOCKARD, JON MCCLELLAND | 1647 | §102§112DP | Non-Final OA | — | Pending | Oct 12, 2023 |
| 16795450 | DUAL PDGF/VEGF ANTAGONISTS | LOCKARD, JON MCCLELLAND | 1647 | §112 | Non-Final OA | 72d overdue | Pending | Feb 19, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial